2009 Annual Meeting | Cerebrovascular Disease

Date Monday 04/27/09

Time 09:00 AM - 05:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Full-Day Course

Director(s) Robert D. Brown, Jr., MD, MPH, FAAN

Topic(s)

Learning Objectives Participants should be familiar with the latest recommendations and controversies regarding the evaluation and management of patients with all stroke types, including acute ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage; be able to initiate optimal secondary prevention strategies after ischemic stroke, including selection of the optimal antithrombotic agent using the most recently published data and appropriate aggressive risk factor management; be able to optimally manage issues related to ischemic stroke in young adults, including patent foramen ovale and prothrombotic states; and understand key issues in the management of unruptured intracranial aneurysms.

CME Available No CME available

Core Competencies Medical Knowledge

Program Level Advanced

Recommended Audience Practitioner, Fellow, Academician, Resident, Nurse

Event Timeline
09:00 AM - 09:40 AM		Optimal Management of Acute Ischemic Stroke Jeffrey L. Saver, MD, FAAN
09:40 AM - 09:55 AM		Questions and Answers Jeffrey L. Saver, MD, FAAN
09:55 AM - 10:35 AM		Causes of Ischemic Stroke in Young Adults: Evaluation and Management Cheryl Bushnell, MD, MHS
10:35 AM - 10:50 AM		Questions and Answers Cheryl Bushnell, MD, MHS
10:50 AM - 11:05 AM		Break
11:05 AM - 11:45 AM		Secondary Prevention After Ischemic Stroke: Using Available Data to Select the Optimal Antithrombotic Therapy J. D. Easton, MD, FAAN
11:45 AM - 12:00 PM		Questions and Answers J. D. Easton, MD, FAAN
12:00 PM - 01:00 PM		Lunch
01:00 PM - 01:40 PM		Secondary Prevention After Ischemic Stroke: Risk Factor Management Ralph L. Sacco, MD, MS, FAHA
01:40 PM - 01:55 PM		Questions and Answers Ralph L. Sacco, MD, MS, FAHA
01:55 PM - 02:35 PM		Update in the Management of Intracerebral Hemorrhage Joseph P. Broderick, MD, FAAN
02:35 PM - 02:50 PM		Questions and Answers Joseph P. Broderick, MD, FAAN
02:50 PM - 03:30 PM		Update in the Management of Subarachnoid Hemorrhage Alejandro A. Rabinstein, MD, FAAN
03:30 PM - 03:45 PM		Questions and Answers Alejandro A. Rabinstein, MD, FAAN
03:45 PM - 04:00 PM		Break
04:00 PM - 04:40 PM		Key Issues in the Management of Unruptured Intracranial Aneurysms Robert D. Brown, Jr., MD, MPH, FAAN
04:40 PM - 04:55 PM		Questions and Answers Robert D. Brown, Jr., MD, MPH, FAAN

Faculty Disclosures
Joseph P. Broderick, MD, FAAN	Dr. Broderick has received publishing royalties from a publication relating to health care.
J. D. Easton, MD, FAAN	No disclosure on file
Ralph L. Sacco, MD, MS, FAHA	Dr. Sacco has received personal compensation in the range of $100,000-$499,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Sacco has received research support from NIH, NINDS, NCATS, NIMHD. The institution of Dr. Sacco has received research support from FL Department of Health. Dr. Sacco has received research support from University of Washington, Seattle. Dr. Sacco has received publishing royalties from a publication relating to health care.
Robert D. Brown, Jr., MD, MPH, FAAN	Dr. Brown has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Craig H Neilsen Foundation. The institution of Dr. Brown has received research support from National Institutes of Health/NINDS. Dr. Brown has received publishing royalties from a publication relating to health care.
Jeffrey L. Saver, MD, FAAN	Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stryker. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerenovus. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boehringer Ingelheim (prevention only). Dr. Saver has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Medical Association. Dr. Saver has received stock or an ownership interest from Rapid Medical.
Cheryl Bushnell, MD, MHS	Dr. Bushnell has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ZZ Biotech. The institution of Dr. Bushnell has received research support from PCORI. The institution of Dr. Bushnell has received research support from AHRQ. The institution of Dr. Bushnell has received research support from NIH/NINDS. Dr. Bushnell has received intellectual property interests from a discovery or technology relating to health care. Dr. Bushnell has received publishing royalties from a publication relating to health care.
Alejandro A. Rabinstein, MD, FAAN	Dr. Rabinstein has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Shionogi . Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chiesi. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ceribell. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurocritical care/NCS-Springer. Dr. Rabinstein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters/UptoDate. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for EBSCO/DynaMed. Dr. Rabinstein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AHA. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care.

��ɫ��

��ɫ��